Cardiac Involvement is Underdiagnosed in Patients with Biopsy-Proven Systemic AL Amyloidosis
Background: Clinical recognition of cardiac involvement and cardiac response to therapy is an important element of clinical care in patients with AL amyloidosis. The new criteria including NT-proBNP, troponin, and echocardiography for assessment of cardiac involvement in patients with systemic AL am...
Main Authors: | Haoyi Zheng, Amitabha Mazumder, Stuart D. Katz |
---|---|
Format: | Article |
Language: | English |
Published: |
Barcaray International
2016-01-01
|
Series: | International Cardiovascular Forum Journal |
Subjects: | |
Online Access: | http://icfjournal.org/index.php/icfj/article/view/172/pdf-2 |
Similar Items
-
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient
by: Giuseppe Vergaro, MD, PhD, et al.
Published: (2021-03-01) -
Senile Systemic Amyloidosis: An Underdiagnosed Disease
by: Marta Catarino Manso, et al.
Published: (2017-09-01) -
Cardiac Amyloidosis – An Underdiagnosed Cause of Heart Failure with Preserved Ejection Fraction – Updated Diagnosis and Treatment Options
by: Roxana Cristina RIMBAS, et al.
Published: (2021-07-01) -
Cardiac involvement in familial amyloidosis with polyneuropathy
by: Eriksson, Peter
Published: (1984) -
Review Article of Cardiac Amyloidosis
by: Jittiporn PURATTANAMAL
Published: (2011-11-01)